Cipher Pharmaceuticals Inc. (CPH) Reports $7.2M Q3 Adjusted EBITDA

Cipher reported Q3 2026 adjusted EBITDA of $7.2M, excluding the non-recurring arbitration award benefit, and $8.5M in operating cash flow. It ended the quarter with $15.3M cash and no debt.Material DetailsContext by AI AnalystThese results provide a quarterly update on Cipher's established commerci…